biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Ghost

<< Previous

Bullboard Posts

Next >>

Comment by TheTruth1234on May 15, 2023 8:30am

137 Views

Post# 35447923

RE:RE:RE:RE:Ghost

Boomskid wrote: Revisionist history, beenthere. You say your actions have been based on my writings and yet you have called me a liar for all of the years that we have appeared here together. I have it documented.

The company will give you something to think about very soon. My guess is that I've already described it.

jd

"The company will give you something to think about very soon. My guess is that I've already described it"

There you go.... classic JD. Always in the "know"!

Always one step ahead hey John?

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale